Profile | GDS2987 / GI_22547196-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 18.8 | 53 |
GSM215244 | HMVEC_vehicle_rep2 | 8.1 | 21 |
GSM215253 | HMVEC_vehicle_rep3 | 22.1 | 56 |
GSM215254 | HMVEC_atorvastatin_rep1 | 37.7 | 64 |
GSM215282 | HMVEC_atorvastatin_rep3 | 24.7 | 49 |
GSM215344 | HMVEC_atorvastatin_rep2 | 1 | 2 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 22.8 | 41 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 51.5 | 66 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 2.7 | 4 |
GSM215294 | HMVEC_SLx2119_rep1 | 18.4 | 53 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 6.5 | 11 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 7.2 | 12 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 7.7 | 14 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 16.3 | 31 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 58.3 | 65 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 178.5 | 80 |
GSM215331 | Fibroblasts_vehicle_rep2 | 208.9 | 82 |
GSM215332 | Fibroblasts_vehicle_rep3 | 188 | 81 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 169.7 | 80 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 176.5 | 80 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 168 | 80 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 188.8 | 81 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 158.9 | 80 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 207.8 | 82 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 223.7 | 82 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 201.8 | 82 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 202 | 81 |